Formulation Featured Articles
-
Advancing Parenteral Manufacturing: The Role Of The RTU Container
10/12/2026
Presterilized vials, syringes, and cartridges reshaped aseptic fill-finish around small batches and multi-format lines. Regulatory fit, material choices, and high-speed filling will define where the technology goes next.
-
Bridging Discovery, Developability, And Commercial Reality
9/29/2026
Driven by metabolic and oncology successes, the expanding peptide therapeutics market faces critical challenges requiring early, customized drug product development, stability, and safety strategies.
-
Exploring The Genetic Tools Enabling Protein Expression In Fruit Flies
9/26/2026
Fruit fly genetics enables precise, scalable protein expression through stable integration, targeted control, inducible regulation, and heritable systems.
-
Engineering Better ADCs, Part 1: MoA, Conjugation Chemistry, And More
9/24/2026
The field has evolved considerably in antibody–drug conjugate (ADC) science. In this first article of a two-part series, let's discuss how to engineer better ADCs, covering MoA, conjugation chemistry, and more.
-
In Vivo Gene Editing Needs Robust Iteration, Not One-Time Optimization
9/22/2026
Gene-editing performance depends on the interaction among editor design, RNA chemistry, guides, delivery, and biology. Learn why iterative optimization across the full system is essential.
-
Can Targeted LNP Delivery Take In-Vivo CAR-T Therapy Beyond The Liver?
9/17/2026
Achieving successful extrahepatic CAR T delivery with LNPs requires addressing the unique biological and technological barriers and designing targeting approaches that leverage innovative LNP design.
-
Risk Managing Through The Void Of ATMP Visible Particle Guidance
9/8/2026
Regulators expect cell therapy manufacturers to prove they control for visible particles, but guidance remains notably quiet on the matter. Companies must get creative or risk clinical holds.
-
Looking Beyond Solubility And Process Performance
9/2/2026
Solvent selection for spray-dried dispersions significantly impacts drug performance, scalability, and supply chains. Early, structured solvent choice is vital for successful manufacturing and commercialization.
-
Expanding Subcutaneous Design Brick By Brick
8/14/2026
Biologics are growing more complex. But what if the syringe itself could unlock new possibilities? Discover the technology “bricks” quietly reshaping subcutaneous drug delivery.
-
Efficient Solutions Supporting Freezing And Storage Operations In Bulk Drug Manufacturing
8/13/2026
Practical strategies for reducing handling steps, minimizing product loss risk, and improving operator efficiency in frozen drug substance cold chain operations.